Temporal bone ORN is a rare but serious complication of head and neck cancer treatment. Medical management, including topical antimicrobials, debridement, PENTO protocol, HBO therapy, and pain relief, can be effective for localized cases. Surgical intervention is recommended for diffuse disease, severe pain, uncontrolled infections, cholesteatomas, and patients over 60. More research and randomized control trials are needed to determine the best treatment approaches.
Elective Neck Dissection does not improve survival rate but may be useful for staging and identifying candidates for treatment intensification, as well as for offering prognostic information to the patient.
Given the high rate of positive surgical margins in head and neck cancer, there is a need to improve margin analysis technique and intraoperative communication protocols.
Join event organizers in Charleston, South Carolina for ocean-front education at the inaugural Head and Neck Oncology Symposium. Our first ever seminar will connect industry-defining leaders in the field of […]
Following this series of in-person lectures, participants should be able to describe and discuss contemporary surgical approaches to the management of head and neck neoplasms and understand the role of […]
Management remains controversial because there is no universally accepted consensus on the threshold for surgical intervention, appropriate treatment strategy, frequency of surveillance, and ablative versus excisional management
A digital signal can be generated using chemical macromolecular cooperativity at the nanoscale to build a transistor-like probe.
Depression at time of treatment planning appeared to be as important a predictor of two-year survival as traditional clinical prognostic indicators.
Experts offer tips on several kinds of head and neck defects and the many factors that go into choosing between a local or regional flap and a free flap reconstruction.
In addition to the known sex-specific cancer types, such as ovarian and prostate cancers, there are significant gender disparities in non-sex-specific cancers, such as rate of incidence and susceptibility, tumor […]